{"id":"anacaulase-bcdb","rwe":[],"tags":[],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Pruritus","drugRate":"","severity":"common","organSystem":""},{"effect":"Pyrexia","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Papayas hypersensitivity","Pineapple hypersensitivity"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Anaphylaxis","drugRate":"","severity":"serious"},{"effect":"Hypersensitivity","drugRate":"","severity":"serious"},{"effect":"Urticaria","drugRate":"","severity":"serious"}]},"status":"approved","trials":["NCT06568627","NCT04040660","NCT02148705","NCT06690177","NCT02278718"],"aliases":[],"company":"MEDIWOUND, LTD","patents":[],"pricing":[],"allNames":"nexobrid","offLabel":[],"timeline":[],"brandName":"NEXOBRID","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small Molecule","drugClass":"","explanation":"","oneSentence":""},"commercial":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://www.fda.gov/drugs","name":"FDA Drugs@FDA","fields":["phase","status","brandName","company"],"retrievedDate":"2026-04-07"},{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"ANACAULASE-BCDB","indications":{"approved":[{"name":"Removal of escars from deep thermal burn","diseaseId":"removal-of-escars-from-deep-thermal-burn","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"currentOwner":"MEDIWOUND, LTD","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06568627","phase":"Phase 3","title":"A Multicenter, Prospective, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of Venous Leg Ulcers (VALUE","status":"RECRUITING","sponsor":"MediWound Ltd","isPivotal":true,"enrollment":216,"indication":"Venous Leg Ulcer (VLU)","completionDate":"2027-03"},{"nctId":"NCT04040660","phase":"N/A","title":"Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries","status":"APPROVED_FOR_MARKETING","sponsor":"MediWound Ltd","isPivotal":false,"enrollment":0,"indication":"Thermal Burn","completionDate":""},{"nctId":"NCT02148705","phase":"Phase 3","title":"A Multicenter, Multinational, Randomized, Controlled, Assessor Blinded Study, Performed in Subjects With Thermal Burns, to Evaluate the Efficacy and Safety of NexoBrid Compared to Gel Vehicle and Comp","status":"COMPLETED","sponsor":"MediWound Ltd","isPivotal":true,"enrollment":175,"indication":"Thermal Burns","completionDate":"2020-08-20"},{"nctId":"NCT06690177","phase":"Phase 2","title":"A Multicenter, Prospective, Randomized, Placebo and Collagenase (Non-surgical Standard-of-care) Controlled Study, Performed to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Form","status":"NOT_YET_RECRUITING","sponsor":"MediWound Ltd","isPivotal":false,"enrollment":45,"indication":"Venus Leg Ulcers","completionDate":"2028-09-30"},{"nctId":"NCT02278718","phase":"Phase 3","title":"A Multicenter, Multinational, Randomized, Controlled, Open Label Study, Performed in Children With Thermal Burns, to Evaluate the Efficacy and Safety of NexoBrid as Compared to Standard of Care (SOC) ","status":"COMPLETED","sponsor":"MediWound Ltd","isPivotal":true,"enrollment":145,"indication":"Thermal Burns","completionDate":"2022-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"TOPICAL","frequency":"","formulation":""},"formularyStatus":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"companyName":"MEDIWOUND, LTD","companyId":"mediwound-ltd","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"NexoBrid is an enzyme-based treatment used for the removal of necrotic tissue. It is being studied for the treatment of acute deep partial and full thickness burn injuries.","enrichmentLevel":3,"visitCount":2,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}